Ultragenyx Pharmaceutical
RARE
14.89
+0.43
+2.97%
Ultragenyx Pharmaceutical
US · RARE
#3012 by market cap
Listed 1970
14.89
+0.43
+2.97%
Live - 5344 symbols - heartbeat 26s ago
· 2026-10-08 07:08
Pre-market
14.63
-1.73%
After-hours
14.85
-0.27%
Overnight
14.89
0.00%
- Market cap
- 1.47B
- P/E (TTM)i
- -2.55
- P/Bi
- -5.04
- EPSi
- -5.83
- Div yieldi
- 0.00%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on RARE?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Goldman Sachs Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy RatingMarket Newswire · 2026/10/4
-
Company notice
Rare Element Resources Ltd. | 3: Initial statement of beneficial ownership of securities- Bilant JosefSEC · 2026/10/6
-
Rating change
Ord Minnett Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Sell Rating, Cuts Target Price to $9.82Market Newswire · 2026/9/29
-
CSL Strikes US$1.6 Billion Licensing Deal for Rare Disease Drug | ASX:CSLProactive Investors · 2026/10/5
-
Mobix Labs Merger Partner Special Project Delivery To Combine With U.S. Rare Earth Company Winner Water Services; Terms Not DisclosedBenzinga · 2026/10/5
-
Ord Minnett Upgrades LYNAS RARE EARTHS LTD(LYSCF.US) to Buy Rating, Raises Target Price to $9.76Market Newswire · 2026/10/5
-
Bond Selloff Is Opening up Rare Opportunities for Investors. Here Is Where to Look, Says Major Bank.MarketWatch · 2026/10/5
-
Rating change
J.P. Morgan Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $13.17Market Newswire · 2026/10/3
-
Company notice
American Rare Earths Ltd: CSM Study Strengthens Foundation for U.S. REE SupplyASX · 2026/9/30
-
Rating change
UBS Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $14.55Market Newswire · 2026/10/2
-
Lynas Rare Earths Price Target Cut 10% to A$18.00/Share by JefferiesDow Jones · 2026/10/5
-
Rating change
William Blair Maintains LYNAS RARE EARTHS LTD SPON ADR EACH REP 1 ORD SHS(LYSDY.US) With Buy RatingMarket Newswire · 2026/10/1
-
Company notice
Shionogi: Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.JPX · 2026/10/5
-
Rating change
H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $25Market Newswire · 2026/9/25
-
Rating change
Lynas Rare Earths Price Target Cut 5% T0 A$19.00/Share by MacquarieDow Jones · 2026/10/2
-
Rating change
Lynas Rare Earths Price Target Cut 6.7% to A$21.00/Share by UBSDow Jones · 2026/10/2
-
Rating change
J.P. Morgan Remains a Buy on Lynas Rare Earths (LYSCF)TipRanks · 2026/10/3
-
Company notice
JX Advanced Metals: Notice Regarding the Agreement on a Joint Study for Entering the Rare Earth Refining Business with Tronox Co., Ltd.JPX · 2026/9/29
-
Rating change
Macquarie Maintains AMERICAN RARE EARTHS LTD(ARRNF.US) With Buy Rating, Cuts Target Price to $0.38Market Newswire · 2026/10/1
-
Company notice
Xiamen Tungsten Co., Ltd.: Notice Regarding the Acceptance of the Application for a Public Offering of Shares and Listing on the Beijing Stock Exchange by Its Controlling Subsidiary, Jinlong Rare EarthSZSI · 2026/10/1
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:08:01 · For reference only, not investment advice and not tailored to your situation.